Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1985-04-05
1987-06-16
Kepplinger, Esther M.
Drug, bio-affecting and body treating compositions
Lymphokine
435237, A61K 3912, C12N 708
Patent
active
046735720
ABSTRACT:
The invention relates to a highly immunogenic virus preparation derived by attenuation employing serial passages in avian cell cultures and six plaque purification steps from a Marek's disease virus strain, belonging to Avian Herpesvirus serotype-1. The original virus strain MDV CVI-988 was recovered from a healthy chicken (Avian Diseases 16: 108-125, 1972).
The live purified Marek's disease vaccine so obtained is innocuous for specific pathogen free Rhode Island Red chickens which are highly susceptible for development of Marek's disease tumors. The monovalent virus preparation, according to the invention, demonstrated in comparison with Marek's disease vaccines based on the same strain, currently in use at a lower cell passage level, an improved protective efficacy against challenge infection by two representatives of virulent Marek's disease virus.
The monovalent virus preparation, according to the invention, provided significantly better protection than current MDV CVI-988 vaccine to challenge infection with a representative of the group of newly emerging very virulent strains of Marek's disease virus, MDV RB/1B. The monovalent virus preparation, according to the invention, provided significantly better protection than is HVT FC126 vaccine to challenge infection with another representative of the group of very virulent MD viruses, MDV Tun.
REFERENCES:
patent: 3642574 (1972-02-01), Okazaki et al.
patent: 3674861 (1972-07-01), Churchill
patent: 3783098 (1974-01-01), Calnek et al.
patent: 4160024 (1979-07-01), Schat et al.
Biostandards (IABS) Geneva, 29-42 (1972).
De Boer et al., J. Biol. Standard., 9: 15-22 (1981).
Bulow, Avian Pathology, 6: 395-403 (1977).
Calnek, J. Nat. Cancer Inst., 51: 929-939 (1973).
Churchill, et al., J. Gen. Virol., 4: 557-564 (1969).
Ikuta et al., J. Gen. Virol., 64: 2597-2610 (1983).
Maas et al., World's Poultry Sci. J., 38: 163-173 (1982).
Okazaki et al., Avian Diseases, 14: 413-429 (1970).
Payne et al., J. Nat'l. Cancer Inst., 39: 281-302 (1967).
Rispens et al., Avian Diseases, 16: 108-138 (1972).
Javma 183(3): 355, Abstract #139, and #140, Aug. 1, 1983.
Von Bulow et al., Avian Path., 4: 133-146 (1975).
Schat et al., J. Nat'l. Cancer Inst., 60: 1075-1082 (1978).
Witter, Avian Diseases, 27: 113-132 (1983).
Witter et al., Avian Path., 13: 75-92 (1984).
Centraal Diergeneeskundig Instituut
Cooper Iver P.
Foley Shawn P.
Kepplinger Esther M.
LandOfFree
Live purified Marek's disease vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Live purified Marek's disease vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Live purified Marek's disease vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-683141